Covid 19 All is connected

Order Of Alpha [Public Channel]
@OrderOfAlpha - OOA

OOA <> [7TEAM]

D1G174L S0LD13R R3-S34RCH
___________________________

A_lie-N push, INCOMING!
THEY ARE DÆ'MONS, OR EXTRATERRESTRIALS IF YOU LIKE IT BETTER THAT WAY.

Order Of Alpha [Public Channel]
@OrderOfAlpha - OOA

OOA <> [7TEAM]

D1G174L S0LD13R R3-S34RCH
___________________________

- OOA7T

DECLAS Coronavirus Patent US10130701

Care to understand how COVID-19 is a false flag political construct that was intentionally developed as a bio-WMD to facilitate the overthrow of the U.S.? Then this article is for you and it includes an abundance of links and other resources to verify positions and provide you with all of the evidence you need for a deeper and clearer understanding of what is being done to us. That’s right – done to us.

On a date conveniently saddled between Christmas and New Year’s Eve 2019, when the majority of the Western world was occupied and distracted with both holiday recovery and preparation, the world fundamentally changed on 27 Dec 19 when the SARS-CoV-2 outbreak (not yet a “pandemic”) was first announced in the mainstream media news. They eased it in and perhaps many missed it.

Order Of Alpha [Public Channel]
@OrderOfAlpha - OOA

OOA <> [7TEAM]

D1G174L S0LD13R R3-S34RCH
___________________________

November 16, 2006

Patent: US2006257852

This web page summarizes information in PubChem about patent US2006257852.

An outbreak of a virulent respiratory virus, now known as Severe Acute Respiratory Syndrome (SARS), was identified in Hong Kong, China and a growing number of countries around the world in 2003. The invention relates to nucleic acids and proteins from the SARS coronavirus. These nucleic acids and proteins can be used in the preparation and manufacture of vaccine formulations, diagnostic reagents, kits, etc. The invention also provides methods for treating SARS by administering small molecule antiviral compounds, as well as methods of identifying potent small molecules for the treatment of SARS.
United States Patent Bickerton et al . ( 10 ) Patent No . : US 10 , 130 , 701 B2 ( 45 ) Date of Patent : Nov . 20 , 2018

Abstract
The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.
Denoscription
FIELD OF THE INVENTION

The present invention relates to an attenuated coronavirus comprising a variant replicase gene, which causes the virus to have reduced pathogenicity. The present invention also relates to the use of such a coronavirus in a vaccine to prevent and/or treat a disease.

https://patents.google.com/patent/US10130701B2/en
https://patentimages.storage.googleapis.com/31/23/d0/e63e0adde2fbad/US10130701.pdf
https://www.uspto.gov/